Christensen Jamie 4
4 · Mirati Therapeutics, Inc. · Filed Jan 18, 2024
Insider Transaction Report
Form 4
Christensen Jamie
SVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-01-16$59.02/sh−631$37,242→ 155,927 total - Sale
Common Stock
2024-01-16$59.02/sh−966$57,013→ 156,558 total
Footnotes (3)
- [F1]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022.
- [F2]Includes 347 shares acquired under the ESPP Purchase on 05/31/2023 and 42 shares acquired under the ESPP purchase on 11/30/2023.
- [F3]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021.